[1]
|
Gunderson, C.C., Nugent, E.K., Elfrink, S.H., et al. (2013) A Contemporary Analysis of Epidemiology and Management of Vaginal Intraepithelial Neoplasia. American Journal of Obstetrics & Gynecology, 208, 410.e1-410.e6.
https://doi.org/10.1016/j.ajog.2013.01.047
|
[2]
|
Murta, E.F.C., Junior, M.A.N., Sempionato, L.R.F., et al. (2005) Vaginal Intraepithelial Neoplasia: Clinical-Therapeutic Analysis of 33 Cases. Archives of Gynecology & Obstetrics, 272, 261-264. https://doi.org/10.1007/s00404-005-0022-1
|
[3]
|
Dodge, J.A., Eltabbakh, G.H., Mount, S.L., et al. (2001) Clinical Features and Risk of Recurrence among Patients with Vaginal Intraepithelial Neoplasia. Gynecologic Oncology, 83, 363-369. https://doi.org/10.1006/gyno.2001.6401
|
[4]
|
Bertoli, H.K., Thomsen, L.T., Iftner, T., et al. (2020) Risk of Vulvar, Vaginal and Anal High-Grade Intraepithelial Neoplasia and Cancer According to Cervical Human Papillomavirus (HPV) Status: A Population-Based Prospective Cohort Study. Gynecologic Oncology, 157, 456-462. https://doi.org/10.1016/j.ygyno.2020.01.030
|
[5]
|
Rome, R.M., England, P.G. (2000) Management of Vaginal Intraepithelial Neoplasia: A Series of 132 Cases with Long-Term Follow-Up. International Journal of Gynecological Cancer, 10, 382-390.
https://doi.org/10.1046/j.1525-1438.2000.010005382.x
|
[6]
|
Hodeib, M., Cohen, J.G., Mehta, S., et al. (2016) Recurrence and Risk of Progression to Lower Genital Tract Malignancy in Women with High Grade VAIN. Gynecologic Oncology, 141, 507-510.
https://doi.org/10.1016/j.ygyno.2016.03.033
|
[7]
|
Chao, A., Chen, T.C., Hsueh, C., et al. (2012) Human Papillomavirus in Vaginal Intraepithelial Neoplasia. International Journal of Cancer, 131, E259-E268. https://doi.org/10.1002/ijc.27354
|
[8]
|
Zhang, J., Chang, X., Qi, Y., et al. (2016) A Retrospective Study of 152 Women with Vaginal Intraepithelial Neoplasia. International Journal of Gynecology & Obstetrics, 133, 80-83. https://doi.org/10.1016/j.ijgo.2015.08.014
|
[9]
|
Minucci, D., Cinel, A., Insacco, E., et al. (1995) Epidemiological Aspects of Vaginal Intraepithelial Neoplasia (VAIN). Clinical and Experimental Obstetrics & Gynecology, 22, 36-42.
|
[10]
|
Sugase, M., Matsukura, T. (1997) Distinct Manifestations of Human Papillomaviruses in the Vagina. International Journal of Cancer, 72, 412-415. https://doi.org/10.1002/(SICI)1097-0215(19970729)72:3<412::AID-IJC7>3.0.CO;2-S
|
[11]
|
Vuyst, H.D., Clifford, G.M., Nascimento, M.C., et al. (2009) Prevalence and Type Distribution of Human Papillomavirus in Carcinoma and Intraepithelial Neoplasia of the Vulva, Vagina and Anus: A Meta-Analysis. International Journal of Cancer, 124, 1626-1636. https://doi.org/10.1002/ijc.24116
|
[12]
|
Smith, J.S., Backes, D.M., Hoots, B.E., et al. (2009) Human Papillomavirus Type-Distribution in Vulvar and Vaginal Cancers and Their Associated Precursors. Obstetrics & Gynecology, 113, 917-924.
https://doi.org/10.1097/AOG.0b013e31819bd6e0
|
[13]
|
Lamos, C., Mihaljevic, C., Aulmann, S., et al. (2016) Detection of Human Papillomavirus Infection in Patients with Vaginal Intraepithelial Neoplasia. PLoS ONE, 11, e0167386. https://doi.org/10.1371/journal.pone.0167386
|
[14]
|
Srodon, M., Stoler, M.H., Baber, G.B., et al. (2006) The Distribution of Low and High-Risk HPV Types in Vulvar and Vaginal Intraepithelial Neoplasia (VIN and VaIN). American Journal of Surgical Pathology, 30, 1513-1518.
https://doi.org/10.1097/01.pas.0000213291.96401.48
|
[15]
|
Alemany, L., Saunier, M., Tinoco, L., et al. (2014) Large Contribution of Human Papillomavirus in Vaginal Neoplastic Lesions: A Worldwide Study in 597 Samples. European Journal of Cancer, 50, 2846-2854.
https://doi.org/10.1016/j.ejca.2014.07.018
|
[16]
|
黄成琳, 张晶, 常晓晗, 等. 阴道病变中宫颈人乳头瘤病毒基因型分布特征分析[J]. 中国实用妇科与产科杂志, 2016, 32(2): 163-167.
|
[17]
|
刘凤勤, 洛若愚. 阴道上皮内瘤变与高危型人乳头瘤病毒感染的相关性[J]. 现代妇产科进展, 2014, 23(2): 134-135.
|
[18]
|
Hampl, M., Wentzensen, N., Vinokurova, S., et al. (2007) Comprehensive Analysis of 130 Multicentric Intraepithelial Female Lower Genital Tract Lesions by HPV Typing and p16 Expression Profile. Journal of Cancer Research and Clinical Oncology, 133, 235-245. https://doi.org/10.1007/s00432-006-0162-0
|
[19]
|
Logani, S. (2003) Low-Grade Vulvar and Vaginal Intraepithelial Neoplasia: Correlation of Histologic Features with Human Papillomavirus DNA Detection and MIB-1 Immunostaining. Modern Pathology, 16, 735-741.
https://doi.org/10.1097/01.MP.0000081051.55284.2A
|
[20]
|
Joura, E.A., Leodolter, S., Hernandez-Avila, M., et al. (2007) Efficacy of a Quadrivalent Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like-Particle Vaccine against High-Grade Vulval and Vaginal Lesions: A Combined Analysis of Three Randomised Clinical Trials. The Lancet, 369, 1693-1702.
https://doi.org/10.1016/S0140-6736(07)60777-6
|
[21]
|
Van Beurden, M., Ten Kate, F.W.J., Tjong-A-Hung, S.P., et al. (1998) Human Papillomavirus DNA in Multicentric Vulvar Intraepithelial Neoplasia. International Journal of Gynecological Pathology, 17, 12-16.
https://doi.org/10.1097/00004347-199801000-00003
|
[22]
|
Daling, J.R., Madeleine, M.M., Schwartz, S.M., et al. (2002) A Population-Based Study of Squamous Cell Vaginal Cancer: HPV and Cofactors. Gynecologic Oncology, 84, 263-270. https://doi.org/10.1006/gyno.2001.6502
|
[23]
|
Bertoli, H.K., Rasmussen, C.L., Sand, F.L., et al. (2019) Human Papillomavirus and p16 in Squamous Cell Carcinoma and Intraepithelial Neoplasia of the Vagina. International Journal of Cancer, 145, 78-86.
https://doi.org/10.1002/ijc.32078
|
[24]
|
Jentschke, M., Hoffmeister, V., Soergel, P., et al. (2015) Clinical Presentation, Treatment and Outcome of Vaginal Intraepithelial Neoplasia. Archives of Gynecology, 293, 415-419. https://doi.org/10.1007/s00404-015-3835-6
|
[25]
|
Bogani, G., Martinelli, F., Ditto, A., et al. (2017) Human Papillomavirus (HPV) Persistence and HPV 31 Predict the Risk of Recurrence in High-Grade Vaginal Intraepithelial Neoplasia. European Journal of Obstetrics & Gynecology and Reproductive Biology, 210, 157-165. https://doi.org/10.1016/j.ejogrb.2016.12.020
|
[26]
|
Baay, M., Verhoeven, V., Wouters, K., et al. (2004) The Prevalence of the Human Papillomavirus in Cervix and Vagina in Low-Risk and High-Risk Populations. Scandinavian Journal of Infectious Diseases, 36, 456-459.
https://doi.org/10.1080/00365540410020677
|
[27]
|
Steben, M., Duarte-Franco, E. (2007) Human Papillomavirus Infection: Epidemiology and Pathophysiology. Gynecologic Oncology, 107, S2-S5. https://doi.org/10.1016/j.ygyno.2007.07.067
|
[28]
|
马莉, 洪颖. 阴道上皮内瘤变与宫颈上皮内瘤变的关联性及高危因素分析[J]. 中国医师杂志, 2015, 17(1): 41-44.
|
[29]
|
Insinga, R.P., Liaw, K.L., Johnson, L.G., et al. (2008) A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United States. Cancer Epidemiology, Biomarkers & Prevention, 17, 1611-1622. https://doi.org/10.1158/1055-9965.EPI-07-2922
|
[30]
|
Bosquet, E.G., Torres, A., Busquets, M., et al. (2008) Prognostic Factors for the Development of Vaginal Intraepithelial Neoplasia. European Journal of Gynaecological Oncology, 29, 43-45.
|